Phytochemical Profiling and Antibacterial Dynamics of Xanthium strumarium L Extract: Unlocking Potential Therapeutic Pathways

This investigation focuses on the analysis of the chemical constituents and possible therapeutic effects of extracts derived from botanical sources. The research entails a quantitative evaluation of phenolic compounds, alkaloids, carotenoids and tannins present in an ethanolic extract from the aerial components of the plant Xanthium strumarium L. Analytical results indicate a considerable presence of these phytochemicals within the extract, with phenolics, alkaloids and carotenoids as predominant constituents. Phenolic compounds represent 19% of the extract, notable for their role in antioxidative activities which are critical in scavenging free radicals and may contribute to lowering the incidence of chronic diseases. Alkaloids, accounting for 12% of the extract, have been recognized for their wide-ranging pharmacological actions. Carotenoids, which constitute 25% of the extract, suggest the extract's potential as a nutraceutical agent for health enhancement and disease prophylaxis. The study underscores the significant levels of these bioactive molecules, reflecting a phytochemical matrix with potential for antioxidative, anti-inflammatory and extensive pharmacological utilities. Additionally, the manuscript investigates the in vitro antibacterial efficacy of the Xanthium extract against various bacterial pathogens. By assessing the extract's minimum inhibitory concentration (MIC) and zone of inhibition (ZOI) and comparing these parameters to those of tetracycline, a standard antibiotic, the research delineates a concentration-dependent antibacterial activity of the extract. It is noteworthy that an increase in the extract's concentration resulted in a reduction in MIC and an augmentation in ZOI, particularly against E. coli and S. aureus, suggesting the extract's potential as an antibacterial agent.